icd10free.comPowered by Curo

ICD-10 Coding for Elevated Carcinoembryonic Antigen(R97.0, R97.1)

Save

Learn about the ICD-10 coding for elevated carcinoembryonic antigen (CEA), including documentation requirements, coding pitfalls, and clinical validation.

Also known as:
Elevated CEAAbnormal CEA levels
Related ICD-10 Code Ranges

Complete code families applicable to Elevated Carcinoembryonic Antigen

R00-R99Primary Range

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

→
Primary ICD-10-CM Codes
Elevated carcinoembryonic antigen [CEA]
R97.0Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Elevated cancer antigen 125 [CA 125]R97.1

Documentation & Coding Risks

Avoid these common issues when documenting Elevated Carcinoembryonic Antigen.

Documenting 'elevated tumor markers' without specificity

Impact

Clinical: Lack of specificity can lead to misinterpretation., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials due to insufficient documentation.

Mitigation

Always specify the type of tumor marker., Include exact values and clinical context.

Using R97.0 as primary code for active cancer

Impact

Reimbursement: Incorrect sequencing can lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation

Sequence the malignancy code first, followed by R97.0.

Use of R97.0 without documented neoplasm

Impact

Coding R97.0 without a documented history of neoplasm can trigger audits.

Mitigation

Ensure documentation includes history or suspicion of malignancy.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with R97.0.